Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00207610 · ClinicalTrials.gov registry record · Phase 3
Iron Supplementation Among Low-Income Postpartum Women
A Phase 3 study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 3
- Development phase
- 959
- Enrollment target
NCT00207610: Completed Phase 3 study, sponsored by Centers for Disease Control and Prevention.
NCT00207610 is a Phase 3 study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 959 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (24% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00207610, a Phase 3 study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 959 participants
- Enrollment target
Study Summary
Anemia is common among low-income women after they have given birth. Anemia, or low hemoglobin in the blood cells, is usually caused by not having enough iron. Blood cells usually carry oxygen to other parts of the body. Without enough hemoglobin, the ability of blood cells to carry oxygen is decreased. Memory and work may be impaired. The purpose of this study is to evaluate three methods of giving iron to prevent anemia among low-income women after they have given birth.
Interventions
- BEHAVIORAL Daily iron supplements of 65 mg a day for 3 months
- BEHAVIORAL Universal anemia screening and treatment
- BEHAVIORAL Selective anemia screening and treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 959 participants |
| Start Date | 2003-06 |
| Est. Completion | 2007-09 |
| Phase | Phase 3 |
What the finished NCT00207610 record still lists
NCT00207610 is an interventional study that assigns participants to a tested intervention. The registered 959 participants enrollment target is mid-sized for trials with a published cap, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (24% higher).
The record links to 0 conditions, and to 3 interventions - of which Daily iron supplements of 65 mg a day for 3 months is the first listed.
NCT00207610 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00207610 about?
NCT00207610 is a clinical study titled "Iron Supplementation Among Low-Income Postpartum Women". Anemia is common among low-income women after they have given birth. Anemia, or low hemoglobin in the blood cells, is usually caused by not having enough iron. Blood cells usually carry oxygen to other parts of the body. Without enough hemoglobin, the ability of blood cells to carry oxygen is decrea...
What is the current status of trial NCT00207610?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 959 participants. The study started on 2003-06. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00207610?
The interventions under investigation include: Daily iron supplements of 65 mg a day for 3 months (BEHAVIORAL), Universal anemia screening and treatment (BEHAVIORAL), Selective anemia screening and treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT00207610?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00207610's enrollment target sits among peer trials
959 332nd of 2000 higher than 1,669 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04726241 · 960 participants · Phase 1
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- NCT05142384 · 960 participants · NA
ICBT (Internet Based Cognitive Behavioral Therapy) for Maternal Depression: Community Implementation in Head Start
- NCT05178498 · 960 participants
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
- NCT05946629 · 960 participants · NA
SELUTION 4 De Novo Small Vessel IDE Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia